{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:19:49Z","timestamp":1788830389539,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054504","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T22:43:22Z","timestamp":1359067402000},"page":"e54504","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis"],"prefix":"10.1371","volume":"8","author":[{"given":"Anne C.","family":"Bay-Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wichuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Byrjalsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morency","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Maksymowych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"ref1","first-page":"S10","article-title":"Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis","volume":"27","author":"RJ Lories","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"ii11","DOI":"10.1093\/rheumatology\/keg327","article-title":"Pathogenesis of bone and cartilage destruction in rheumatoid arthritis","volume":"42","author":"SR Goldring","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","first-page":"S16","article-title":"Mortality, course of disease and prognosis of patients with ankylosing spondylitis","volume":"20","author":"J Braun","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","article-title":"Pathogenesis of ankylosing spondylitis","volume":"6","author":"LS Tam","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3899\/jrheum.090122","article-title":"Entheses and bones in spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)","volume":"36","author":"RA Colbert","year":"2009","journal-title":"J Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13547500902777608","article-title":"Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development","volume":"14","author":"MA Karsdal","year":"2009","journal-title":"Biomarkers"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1756-0500-4-407","article-title":"Identification of the Calcitonin receptor in osteoarthritic chondrocytes","volume":"4","author":"T Segovia-Silvestre","year":"2011","journal-title":"BMC Res Notes"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/adt.2005.3.553","article-title":"In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?","volume":"3","author":"S Schaller","year":"2005","journal-title":"Assay Drug Dev Technol"},{"key":"ref9","first-page":"P51","article-title":"The CII fragments Helix-II and CTX-II reveal distinct enzymatic pathways of cartilage collagen degradation: diagnostic and therapeutic implications in rheumatoid arthritis and osteoarthritis","volume":"52","author":"P Garnero","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.berh.2010.05.009","article-title":"Soluble and tissue biomarkers in ankylosing spondylitis","volume":"24","author":"VK de","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","article-title":"Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis","volume":"56","author":"WP Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","article-title":"Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM--increased serum CIIM in subjects with severe radiographic osteoarthritis","volume":"44","author":"AC Bay-Jensen","year":"2011","journal-title":"Clin Biochem"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, <etal>et al<\/etal>.. (2010) A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem <italic>In press<\/italic>.","DOI":"10.1016\/j.clinbiochem.2010.03.012"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Bay-Jensen AC, Leeming DJ, Kleyer A, Veidal SS, Schett G, <etal>et al<\/etal>.. (2011) Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int.","DOI":"10.1007\/s00296-011-2237-8"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1478-3231.2010.02309.x","article-title":"Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis","volume":"30","author":"SS Veidal","year":"2010","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4137\/BMI.S6347","article-title":"Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis","volume":"6","author":"E Vassiliadis","year":"2011","journal-title":"Biomark Insights"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Vassiliadis E, Veidal SS, Simonsen H, Larsen DV, Vainer B, <etal>et al<\/etal>.. (2011) Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis. Biomarkers .","DOI":"10.3109\/1354750X.2011.584131"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"LS van der","year":"1984","journal-title":"Arthritis Rheum"},{"key":"ref19","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"S Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"64","author":"MC Creemers","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3899\/jrheum.090346","article-title":"Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria","volume":"36","author":"WP Maksymowych","year":"2009","journal-title":"J Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3899\/jrheum090347","article-title":"Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design","volume":"36","author":"WP Maksymowych","year":"2009","journal-title":"J Rheumatol"},{"key":"ref23","first-page":"966","article-title":"Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review","volume":"26","author":"J Ruof","year":"1999","journal-title":"J Rheumatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1136\/ard.2007.078972","article-title":"Joint remodelling in inflammatory disease","volume":"66","author":"G Schett","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref25","first-page":"S33","article-title":"Inflammation and repair mechanisms","volume":"27","author":"G Schett","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"ref26","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"A Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"ref27","first-page":"862","article-title":"Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment","volume":"34","author":"C Lukas","year":"2007","journal-title":"J Rheumatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.22627","article-title":"Validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging spinal inflammation index: is it necessary to score the entire spine?","volume":"57","author":"WP Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.20075","article-title":"Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis","volume":"51","author":"AJ Wanders","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24838","article-title":"Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis","volume":"61","author":"MK de Vries","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","article-title":"Collagens--structure, function, and biosynthesis","volume":"55","author":"K Gelse","year":"2003","journal-title":"Advanced Drug Delivery Reviews"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T21:44:20Z","timestamp":1562622260000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054504"}},"subtitle":[],"editor":[{"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054504","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}